Reasons may always be subject to conjecture. Why Ma left is opened to speculation just as with anyone getting a new position at another company.
I know what you are thinking. Why would anyone settle for a position at CYGX when there are plenty of big name biopharmas out there he could hook up with? That is the million dollar question. Plus the fact that he will be working with other world class scientists both at CYGX and in acedemia/healthcare throughout the country.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.